These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 30061296)
21. Prevalence of β-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants. Luo Y; Yang J; Zhang Y; Ye L; Wang L; Guo L Int J Antimicrob Agents; 2011 Apr; 37(4):352-5. PubMed ID: 21376540 [TBL] [Abstract][Full Text] [Related]
22. Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam. Khalid A; Lubián AF; Ma L; Lin RCY; Iredell JR Int J Infect Dis; 2020 Apr; 93():252-257. PubMed ID: 32061861 [TBL] [Abstract][Full Text] [Related]
23. DHA-1-producing Klebsiella pneumoniae in a teaching hospital in the Czech Republic. Empel J; Hrabák J; Kozińska A; Bergerová T; Urbášková P; Kern-Zdanowicz I; Gniadkowski M Microb Drug Resist; 2010 Dec; 16(4):291-5. PubMed ID: 20624093 [TBL] [Abstract][Full Text] [Related]
24. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Lee K; Yong D; Choi YS; Yum JH; Kim JM; Woodford N; Livermore DM; Chong Y Int J Antimicrob Agents; 2007 Feb; 29(2):201-6. PubMed ID: 17204406 [TBL] [Abstract][Full Text] [Related]
26. Genomic Characterization of Two KPC-Producing Klebsiella Isolates Collected in 1997 in New York City. Eilertson B; Chen L; Chavda KD; Kreiswirth BN Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167551 [No Abstract] [Full Text] [Related]
27. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Villegas MV; Lolans K; Correa A; Suarez CJ; Lopez JA; Vallejo M; Quinn JP; Antimicrob Agents Chemother; 2006 Aug; 50(8):2880-2. PubMed ID: 16870793 [TBL] [Abstract][Full Text] [Related]
28. Selection of SHV extended-spectrum-beta-lactamase-dependent cefotaxime and ceftazidime resistance in Klebsiella pneumoniae requires a plasmid-borne blaSHV gene. Hammond DS; Harris T; Bell J; Turnidge J; Giffard PM Antimicrob Agents Chemother; 2008 Feb; 52(2):441-5. PubMed ID: 17999968 [TBL] [Abstract][Full Text] [Related]
29. Deceiving Phenotypic Susceptibility Results on a Realegeno S; Ward K; Garner OB; Yang S Front Cell Infect Microbiol; 2021; 11():561880. PubMed ID: 33791229 [TBL] [Abstract][Full Text] [Related]
30. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan. Yan JJ; Ko WC; Jung YC; Chuang CL; Wu JJ J Clin Microbiol; 2002 Sep; 40(9):3121-6. PubMed ID: 12202541 [TBL] [Abstract][Full Text] [Related]
31. Cooccurrence of Multiple AmpC β-Lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis in Tunisia. Chérif T; Saidani M; Decré D; Boutiba-Ben Boubaker I; Arlet G Antimicrob Agents Chemother; 2016 Jan; 60(1):44-51. PubMed ID: 26459902 [TBL] [Abstract][Full Text] [Related]
32. Clonal relatedness and plasmid profiling of extensively drug-resistant New Delhi metallo-β-lactamase-producing Qamar MU; Ejaz H; Walsh TR; Shah AA; Al Farraj DA; Alkufeidy RM; Alkubaisi NA; Saleem S; Jahan S Future Microbiol; 2021 Mar; 16():229-239. PubMed ID: 33625250 [No Abstract] [Full Text] [Related]
33. Optimal phenotypic testing of AmpC beta-lactamases using boronic acid solutions. Su WY; Gottlieb T; Merlino J Eur J Clin Microbiol Infect Dis; 2012 Jan; 31(1):49-51. PubMed ID: 21533876 [TBL] [Abstract][Full Text] [Related]
34. Within-patient plasmid dynamics in Klebsiella pneumoniae during an outbreak of a carbapenemase-producing Klebsiella pneumoniae. Stohr JJJM; Verweij JJ; Buiting AGM; Rossen JWA; Kluytmans JAJW PLoS One; 2020; 15(5):e0233313. PubMed ID: 32421705 [TBL] [Abstract][Full Text] [Related]
36. Occurrence and molecular characterization of Klebsiella pneumoniae ST37 clinical isolates producing plasmid-mediated AmpC recovered over a 3-year period. Illiaquer M; Caroff N; Bémer P; Aubin GG; Juvin ME; Lepelletier D; Reynaud A; Corvec S Diagn Microbiol Infect Dis; 2012 Sep; 74(1):95-7. PubMed ID: 22749243 [TBL] [Abstract][Full Text] [Related]
37. Emergence of the third-generation cephalosporin-resistant hypervirulent Klebsiella pneumoniae due to the acquisition of a self-transferable bla Xie Y; Tian L; Li G; Qu H; Sun J; Liang W; Li X; Wang X; Deng Z; Liu J; Ou HY Virulence; 2018 Dec; 9(1):838-844. PubMed ID: 29683780 [No Abstract] [Full Text] [Related]
38. Phenotypic Identification and Genotypic Characterization of Plasmid-Mediated AmpC β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Iran. Robatjazi S; Nikkhahi F; Niazadeh M; Amin Marashi SM; Peymani A; Javadi A; Kashani AH Curr Microbiol; 2021 Jun; 78(6):2317-2323. PubMed ID: 33837818 [TBL] [Abstract][Full Text] [Related]
39. Molecular characterization and epidemiology of cefoxitin resistance among Enterobacteriaceae lacking inducible chromosomal ampC genes from hospitalized and non-hospitalized patients in Algeria: description of new sequence type in Klebsiella pneumoniae isolates. Gharout-Sait A; Touati A; Guillard T; Brasme L; de Champs C Braz J Infect Dis; 2015; 19(2):187-95. PubMed ID: 25636192 [TBL] [Abstract][Full Text] [Related]
40. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Cai JC; Zhou HW; Zhang R; Chen GX Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]